Seelos Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Seelos Therapeutics

07/08/2021 19:58

* Seelos Therapeutics Inc  SEEL.OQ  reported a quarterly
adjusted loss of 8 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 12 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Seelos Therapeutics Inc's reported EPS for the quarter was a
loss of 10 cents​.
* The mean earnings estimate of analysts had risen by
about 11.4% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Seelos Therapeutics Inc shares had fallen by 18.6% this
quarter and gained 36.1% so far this year.
* The company reported a quarterly loss of $8.86 million.
* Wall Street's median 12-month price target for Seelos
Therapeutics Inc is $9.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 7 at 06:57 p.m.  ​All
figures in US dollars unless otherwise stated